ASCO 2024

Article collection

We are proud to present a special collection of articles for the American Society of Clinical Oncology Annual Meeting 2024. This curated selection showcases the cutting-edge advancements and novel perspectives published in journals from Elsevier's Oncology Journal Network. We invite you to explore this collection and delve deeper into the exciting advancements shaping the future of cancer research.

Annals of Oncology

• Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 新しいタブ／ウィンドウで開く

• Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047] 新しいタブ／ウィンドウで開く

Blood Neoplasia

• Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination 新しいタブ／ウィンドウで開く

Cancer Epidemiology

• Risk factors for early-onset colorectal cancer: A Canadian prospective cohort study 新しいタブ／ウィンドウで開く

• Metformin’s role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study 新しいタブ／ウィンドウで開く

Cancer Letters

• Organoid: Bridging the gap between basic research and clinical practice 新しいタブ／ウィンドウで開く

• SPOP-mutant prostate cancer: Translating fundamental biology into patient care 新しいタブ／ウィンドウで開く

Cancer Pathogenesis and Therapy

• PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer 新しいタブ／ウィンドウで開く

• Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus 新しいタブ／ウィンドウで開く

• Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018) 新しいタブ／ウィンドウで開く

Cancer Treatment Reviews

• Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials 新しいタブ／ウィンドウで開く

• First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States 新しいタブ／ウィンドウで開く

Clinical Breast Cancer

• Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survival 新しいタブ／ウィンドウで開く

• Robotics in Screening, Diagnosis and Treatment of Breast Cancer: A Perspective View 新しいタブ／ウィンドウで開く

• Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics 新しいタブ／ウィンドウで開く

Clinical Colorectal Cancer

• Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence 新しいタブ／ウィンドウで開く

• Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review 新しいタブ／ウィンドウで開く

• A Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapy 新しいタブ／ウィンドウで開く

Clinical Genitourinary Cancer

• Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy 新しいタブ／ウィンドウで開く

• Cystic Pelvic Masses in Men: A Presentation of Uncommon Cases and a Literature Review 新しいタブ／ウィンドウで開く

• The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence 新しいタブ／ウィンドウで開く

Clinical Lung Cancer

• Lung Cancer in Women: The Past, Present, and Future 新しいタブ／ウィンドウで開く

• Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges 新しいタブ／ウィンドウで開く

• Personalised Assessment and Rapid Intervention in Frail Patients With Lung Cancer: The Impact of an Outpatient Occupational Therapy Service 新しいタブ／ウィンドウで開く

Clinical Lymphoma Myeloma and Leukemia

• Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma 新しいタブ／ウィンドウで開く

• Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial 新しいタブ／ウィンドウで開く

• Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable 新しいタブ／ウィンドウで開く

Clinics

• Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrence 新しいタブ／ウィンドウで開く

• Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy 新しいタブ／ウィンドウで開く

• Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer 新しいタブ／ウィンドウで開く

Critical Reviews in Oncology/Hematology

• A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications 新しいタブ／ウィンドウで開く

• Oncogenic fusions: Targeting NTRK 新しいタブ／ウィンドウで開く

• Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics 新しいタブ／ウィンドウで開く

ESMO Gastrointestinal Oncology

• Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK 新しいタブ／ウィンドウで開く

• Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status 新しいタブ／ウィンドウで開く

ESMO Open

• Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial 新しいタブ／ウィンドウで開く

• Antibody–drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here? 新しいタブ／ウィンドウで開く

ESMO Real World Data and Digital Oncology

• Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data 新しいタブ／ウィンドウで開く

• Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC) 新しいタブ／ウィンドウで開く

Gynecologic Oncology

• Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update 新しいタブ／ウィンドウで開く

• Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis 新しいタブ／ウィンドウで開く

• Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer 新しいタブ／ウィンドウで開く

• A personalized probabilistic approach to ovarian cancer diagnostics 新しいタブ／ウィンドウで開く

Gynecologic Oncology Reports

• Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine 新しいタブ／ウィンドウで開く

• The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia 新しいタブ／ウィンドウで開く

• Quality corner: Safely using cephalosporins in almost all patients with penicillin allergies: Mini-review and suggested protocol to improve efficacy and surgical outcomes 新しいタブ／ウィンドウで開く

• Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions 新しいタブ／ウィンドウで開く

Immuno-Oncology and Technology

• Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial 新しいタブ／ウィンドウで開く

• Engineering approaches for innate immune-mediated tumor microenvironment remodeling 新しいタブ／ウィンドウで開く

Journal of Cancer Policy

• Implications of FDA’s marketing authorization of hereditary cancer testing 新しいタブ／ウィンドウで開く

• INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas 新しいタブ／ウィンドウで開く

Journal of the National Cancer Center

• Cancer incidence and mortality in China, 2016 新しいタブ／ウィンドウで開く

• Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data 新しいタブ／ウィンドウで開く

• The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy 新しいタブ／ウィンドウで開く

Journal of Thoracic Oncology

• Read here for the Journal of Thoracic Oncology ASCO articles. 新しいタブ／ウィンドウで開く

Leukemia Research

• CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123 新しいタブ／ウィンドウで開く

• Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b 新しいタブ／ウィンドウで開く

• The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms 新しいタブ／ウィンドウで開く

Leukemia Research Reports

• Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas 新しいタブ／ウィンドウで開く

• Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literature 新しいタブ／ウィンドウで開く

• Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy 新しいタブ／ウィンドウで開く

Magnetic Resonance Imaging

• Delineation of the internal iliac vein using MRI with true FISP sequence in patients with locally recurrent rectal cancer: A pilot study using CT/MRI fusion 新しいタブ／ウィンドウで開く

Neoplasia

• Interdisciplinary care of children with diffuse midline glioma 新しいタブ／ウィンドウで開く

Oral Oncology

• HER2-targeted therapies for salivary gland cancers 新しいタブ／ウィンドウで開く

• Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma 新しいタブ／ウィンドウで開く

Oral Oncology Reports

• Salivary exosomes as biomarkers for early diagnosis of oral squamous cell carcinoma 新しいタブ／ウィンドウで開く

Radiation Medicine and Protection

• Comparison of pencil beam and Monte Carlo calculations with ion chamber array measurements for patient-specific quality assurance 新しいタブ／ウィンドウで開く

• Alzheimer's disease and low-dose radiation therapy: A new hope 新しいタブ／ウィンドウで開く

• Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer (2024 edition) 新しいタブ／ウィンドウで開く

Seminars in Oncology

• PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics 新しいタブ／ウィンドウで開く

• PARP inhibitors for prostate cancer 新しいタブ／ウィンドウで開く

Surgical Oncology Insight

• The effect of the pandemic on colorectal cancer in the United States: an increased disease burden 新しいタブ／ウィンドウで開く

• Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancer 新しいタブ／ウィンドウで開く

• Malignant Bowel Obstruction: Historical Lessons, Current Trends, and Future Directions 新しいタブ／ウィンドウで開く

• Implementation of the 2015 American Thyroid Association Guideline Changes Across a Health System: A Quality Improvement Opportunity 新しいタブ／ウィンドウで開く

The Breast

• Platinum chemotherapy for early triple-negative breast cancer 新しいタブ／ウィンドウで開く

• Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial 新しいタブ／ウィンドウで開く

• Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers 新しいタブ／ウィンドウで開く

The Journal of Liquid Biopsy

• Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 新しいタブ／ウィンドウで開く

• Liquid biopsy: Cell-free DNA based analysis in breast cancer 新しいタブ／ウィンドウで開く

• New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights 新しいタブ／ウィンドウで開く

ESMO Podcasts

Listen to the most recent podcasts from the ESMO portfolio.

🎙️ ADCs in HER2+ metastatic breast cancer brain metastases - ESMO Podcasts 新しいタブ／ウィンドウで開く

🎙️ Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer by ESMO Podcasts (soundcloud.com)

Oncology journal network

We’ll help you find the right home for your research – fast

Publishing your work can be time-consuming, especially if the first journal you submit to isn’t right for your research. With over 40 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters,  Elsevier’s Oncology Journal Network 新しいタブ／ウィンドウで開く has the right home for your research. And with our transfer service, you’ll benefit from a smooth, simple publishing process.